Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion type Assertion NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_head.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion wasGeneratedBy ECO_0000203 NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_provenance.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion wasDerivedFrom befree-2016 NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_provenance.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion SIO_000772 24449825 NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_provenance.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion evidence source_evidence_literature NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_provenance.
- NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_assertion description "[Our results show that deletion or methylation of CDKN2A is relatively common in pretreatment follicular lymphoma biopsy specimens and defines a group of cases associated with reduced survival in the rituximab era presumably on the basis of more aggressive disease biology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147387.RAxSQ0HZhE1km0U-g8pjoOnJG6VVSHINUYxM-LOpzuUSk130_provenance.